<DOC>
	<DOCNO>NCT02527005</DOCNO>
	<brief_summary>Randomized control single blind prospective comparative study</brief_summary>
	<brief_title>A Comparative Study Azithromycin S-P Prophylaxis Pregnant HIV+ Patients</brief_title>
	<detailed_description>This study intend randomize control single blind prospective comparative study conduct compare efficacy three monthly dos sulphadoxine-pyrimethamine intermittent preventive therapy malaria azithromycin HIV positive pregnant woman</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Pregnant HIV positive patient , Gestational age 16 week , No history azithromycin sulphadoxinepyrimethamine use four week prior recruitment Anaemia pack cell volume le 30 % , preexist medical condition diabetes mellitus , hypertension , allergy sulphadoxinepyrimethamine azithromycin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>IPT</keyword>
	<keyword>malaria</keyword>
	<keyword>pregnant</keyword>
	<keyword>HIV positive</keyword>
</DOC>